200
Participants
Start Date
October 31, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2027
de-escalation or discontinuation of therapy
De-escalation of therapy, defined as a step-down from maintenance with advanced therapy (biologic or synthetic small molecule) to oral aminosalicylate-based therapy or complete discontinuation of therapy if they are allergic or intolerant to aminosalicylate-based therapy. If patients are receiving immunomodulator or oral aminosalicylate maintenance therapy, they will be de-escalated to complete discontinuation of therapy.
continuation of current therapy
continuation of current maintenance medical therapy for ulcerative colitis
University of Chicago, Chicago
University of Chicago
OTHER